全文获取类型
收费全文 | 2036篇 |
免费 | 147篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 48篇 |
妇产科学 | 29篇 |
基础医学 | 331篇 |
口腔科学 | 30篇 |
临床医学 | 157篇 |
内科学 | 494篇 |
皮肤病学 | 65篇 |
神经病学 | 192篇 |
特种医学 | 38篇 |
外科学 | 213篇 |
综合类 | 13篇 |
预防医学 | 92篇 |
眼科学 | 23篇 |
药学 | 187篇 |
中国医学 | 3篇 |
肿瘤学 | 254篇 |
出版年
2024年 | 3篇 |
2023年 | 32篇 |
2022年 | 42篇 |
2021年 | 72篇 |
2020年 | 39篇 |
2019年 | 52篇 |
2018年 | 58篇 |
2017年 | 50篇 |
2016年 | 66篇 |
2015年 | 64篇 |
2014年 | 77篇 |
2013年 | 101篇 |
2012年 | 148篇 |
2011年 | 187篇 |
2010年 | 94篇 |
2009年 | 73篇 |
2008年 | 141篇 |
2007年 | 157篇 |
2006年 | 128篇 |
2005年 | 132篇 |
2004年 | 130篇 |
2003年 | 117篇 |
2002年 | 96篇 |
2001年 | 12篇 |
2000年 | 6篇 |
1999年 | 13篇 |
1998年 | 27篇 |
1997年 | 13篇 |
1996年 | 12篇 |
1995年 | 6篇 |
1994年 | 2篇 |
1993年 | 9篇 |
1992年 | 5篇 |
1991年 | 3篇 |
1990年 | 5篇 |
1988年 | 2篇 |
1987年 | 3篇 |
1986年 | 1篇 |
1984年 | 3篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1979年 | 1篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1975年 | 4篇 |
1972年 | 1篇 |
1971年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有2194条查询结果,搜索用时 15 毫秒
71.
Mami Ishikawa Shohei Koyama Tadashi Ikegami Hisayuki Fukutomi Takeshi Gohongi Kenji Yuzawa Katashi Fukao Masachika Fujiwara Keiji Fujii 《Journal of gastroenterology》1995,30(4):529-533
A case of extensive extra-and intrahepatic portal tumor thrombosis, with no metastatic foci in liver parenchyma, secondary to advanced gastric carcinoma in a 69-year-old man is reported. The portal tumor thrombosis was characterized by enlargement of the thrombosed segment of the vein, decreased density mass without intraluminal enhancement of the involved vein, nonvisualization of the portal venous branch in the involved lobe, and the so-called cavernous transformation of the portal vein. The surgically resected gastric specimen showed Borrmann type 3 advanced papillary adenocarcinoma. The portal tumor thrombus is presumed to have arisen from vascular invasion in the primary foci of gastric carcinoma, and then to have permeated the portal vein without invasion of liver parenchyma. 相似文献
72.
73.
74.
Yasuo Sasagawa Takuya Akai Satoko Nakada Hiroshi Minato Osamu Tachibana Takayuki Nojima Hideaki Iizuka 《Acta neurochirurgica》2014,156(4):681-687
Background
Narrow-band imaging (NBI) has been confirmed as a useful endoscopic technique to distinguish neoplasm from normal tissue, on the basis of the enhanced neovascularity of tumor tissue. NBI-guided tissue biopsy for laryngopharyngeal and digestive lesions is a novel methodology, but the feasibility for central nervous system tumors remains unclear. The aim of our study was to evaluate the feasibility of NBI-guided biopsy for intraventricular and paraventricular tumor.Methods
Fourteen patients with intraventricular or paraventricular tumors underwent neuroendoscopic biopsy using a videoscope with NBI. Ventricular walls and tumors were observed using conventional imaging, followed by NBI. Colors of ventricle walls and tumors visualized using NBI were compared to those visualized under conventional imaging. Extracted specimens were stained using CD31 antibody and numbers of microvessels in each specimen were counted for analyzing vascular density.Results
Normal ventricle walls were a similar color under conventional imaging and NBI. Tumor surfaces appeared to be cyan in color under NBI. Vessels on the tumor were more clearly visualized with NBI than with conventional imaging. NBI was able to identify tumor surfaces that were not perceptible on conventional imaging. All specimens in the lesion surfaces from cyan-colored areas under NBI contained tumor cells. Specimens extracted from regions that appeared cyan in color under NBI (51.0 vessels/mm2) had significantly greater vascular density than regions that appeared a normal color (17.4 vessels/mm2; p = 0.039).Conclusion
NBI-guided biopsy of intraventricular and paraventricular tumors is feasible for visualizing tumor surface-enhancing neovascularities. NBI would contribute to accurate histological diagnosis while minimizing injury to surrounding structures. 相似文献75.
Mitsuro Chiba Satoko Tsuda Tsuyotoshi Tsuji Kunio Nakane Masafumi Komatsu Yoshiko Miura Toshiya Ishida Toru Shibahara Tadashi Nishimoto 《Medicine》2014,93(7)
There is limited information in the use of antitumor necrosis factor α, infliximab, in patients on hemodialysis. In Crohn’s disease (CD), only 3 cases are reported.A 76-year-old man on hemodialysis for renal failure caused by immunoglobulin A nephropathy developed diarrhea and abdominal pains. A marked edema was observed in the pretibia and ankle. An increase of C-reactive protein (CRP) and erythrocyte sedimentation rate, hypoalbuminemia, hypocholesterolemia, and moderate anemia was found. Ultrasonography and computed tomography (CT) found wall thickness in the left colon. Sigmoidoscopy revealed multiple ulcers in the sigmoid colon and noncaseating epithelioid granuloma was found in the biopsy specimen. Barium enema study exhibited collar button signs and longitudinal ulcers in the left colon.A severe form of CD was diagnosed. Metronidazole seemed to decrease CRP but was ineffective in ameliorating diarrhea. Infliximab rather than steroid hormone was chosen for the treatment. Standard induction therapy with infliximab was initiated. Symptoms rapidly improved then disappeared. CD activity index decreased from 747 to a remission level of 134 after 2 infusions of infliximab. Scheduled maintenance infliximab therapy was administered after the induction therapy. Ultrasonography and CT showed a disappearance of the wall thickness of the colon. Adverse reactions were not observed.Infliximab was effective and safe in a patient with CD on hemodialysis. Our case has added additional literature in accordance with previous reports supporting infliximab as effective and safe in patients on hemodialysis. 相似文献
76.
Kei Kawana Katsuyuki Adachi Satoko Kojima Ayumi Taguchi Kensuke Tomio Aki Yamashita Haruka Nishida Kazunori Nagasaka Takahide Arimoto Terufumi Yokoyama Osamu Wada-Hiraike Katsutoshi Oda Tomomitsu Sewaki Yutaka Osuga Tomoyuki Fujii 《Vaccine》2014
Background
Cervical intraepithelial neoplasia grade 3 (CIN3) is a mucosal precancerous lesion caused by high-risk human papillomavirus (HPV). Induction of immunological clearance of CIN3 by targeting HPV antigens is a promising strategy for CIN3 therapy. No successful HPV therapeutic vaccine has been developed.Methods
We evaluated the safety and clinical efficacy of an attenuated Lactobacillus casei expressing modified full-length HPV16 E7 protein in patients with HPV16-associated CIN3. Ten patients were vaccinated orally during dose optimization studies (1, 2, 4, or 6 capsules/day) at weeks 1, 2, 4, and 8 (Step 1). Seven additional participants were only tested using the optimized vaccine formulation (Step 2), giving a total of 10 patients who received optimized vaccination. Cervical lymphocytes (CxLs) and peripheral blood mononuclear cells (PBMCs) were collected and E7 specific interferon-γ-producing cells were counted (E7 cell-mediated immune responses: E7-CMI) by ELISPOT assay. All patients were re-evaluated 9 weeks after initial vaccine exposure using cytology and biopsy to assess pathological efficacy.Results
No patient experienced an adverse event. E7-CMI in both CxLs and PBMCs was negligible at baseline. All patients using 4–6 capsules/day showed increased E7-CMI in CxLs, whereas patients using 1–2 capsules/day did not. No patient demonstrated an increase in E7-CMI in their PBMCs. In comparison between patients of cohorts, E7-CMI at week 9 (9 wk) in patients on 4 capsules/day was significantly higher than those in patients on 1, 2, or 6 capsules/day. Most patients (70%) taking the optimized dose experienced a pathological down-grade to CIN2 at week 9 of treatment. E7-CMI in CxLs correlated directly with the pathological down-grade.Conclusions
Oral administration of an E7-expressing Lactobacillus-based vaccine can elicit E7-specific mucosal immunity in the uterine cervical lesions. We are the first to report a correlation between mucosal E7-CMI in the cervix and clinical response after immunotherapy in human mucosal neoplasia. 相似文献77.
78.
79.
Yoko Hiraki Satoko Miyatake Michiko Hayashidani Yutaka Nishimura Hiroo Matsuura Masahiro Kamada Takuji Kawagoe Keiji Yunoki Nobuhiko Okamoto Hiroko Yofune Mitsuko Nakashima Yoshinori Tsurusaki Hirotomo Satisu Akira Murakami Noriko Miyake Gen Nishimura Naomichi Matsumoto 《American journal of medical genetics. Part A》2014,164(1):231-236
80.
Ayako Sakakibara Kei Kohno Eri Ishikawa Yuka Suzuki Yuta Tsuyuki Satoko Shimada Kazuyuki Shimada Akira Satou Taishi Takahara Akiko Ohashi Emiko Takahashi Seiichi Kato Shigeo Nakamura Naoko Asano 《Journal of Clinical and Experimental Hematopathology》2021,61(4):182
The programmed cell death 1 (PD1)/PD1 ligand (PD-L1) axis plays an important role in tumor cell escape from immune control and has been most extensively investigated for therapeutic purposes. However, PD-L1 immunohistochemistry is still not used widely for diagnosis. We review the diagnostic utility of PD-L1 (by clone SP142) immunohistochemistry in large-cell lymphomas, mainly consisting of classic Hodgkin lymphoma (CHL) and diffuse large B-cell lymphoma (DLBCL). Neoplastic PD-L1 (nPD-L1) expression on Hodgkin and Reed-Sternberg cells is well-established among prototypic CHL. Of note, EBV+ CHL often poses a challenge for differential diagnosis from peripheral T-cell lymphoma with EBV+ non-malignant large B-cells; their distinction is based on the lack of PD-L1 expression on large B-cells in the latter. The nPD-L1 expression further provides a good diagnostic consensus for CHL with primary extranodal disease conceivably characterized by a combined pathogenesis of immune escape of tumor cells and immunodeficiency. Compared with CHL, the nPD-L1 expression rate is much lower in DLBCL, highlighting some specific subgroups of intravascular large B-cell lymphoma, primary mediastinal large B-cell lymphoma, and EBV+ DLBCL. They consist of nPD-L1-positive and -negative subgroups, but their clinicopathological significance remains to be elucidated. Microenvironmental PD-L1 positivity on immune cells may be associated with a favorable prognosis in extranodal DLBCL. PD-L1 (by SP142) immunohistochemistry has helped us to understand the immune biology of lymphoid neoplasms possibly related by immune escape and/or immunodeficiency. However, knowledge of these issues remains limited and should be clarified for diagnostic consensus in the future. 相似文献